Literature DB >> 17288879

Induction chemotherapy for squamous cancer of the head and neck.

Merrill S Kies1.   

Abstract

This paper reviews the efficacy and hazard of sequential combined treatment programs for squamous cell carcinoma of the head and neck. These regimens consist of initial systemic chemotherapy, known as neoadjuvant or induction chemotherapy, followed by radiation with or without concomitant chemotherapy.

Entities:  

Mesh：

Year:  2007        PMID： 17288879     DOI： 10.1007/s11912-007-0010-7

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  29 in total

1.  Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma.

Authors:  G Calais; M Alfonsi; E Bardet; C Sire; T Germain; P Bergerot; B Rhein; J Tortochaux; P Oudinot; P Bertrand
Journal:  J Natl Cancer Inst       Date:  1999-12-15       Impact factor: 13.506

2.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

3.  Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial.

Authors:  B Jeremic; Y Shibamoto; B Milicic; N Nikolic; A Dagovic; J Aleksandrovic; Z Vaskovic; L Tadic
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

Review 4.  The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck.

Authors:  M R Posner; A D Colevas; R B Tishler
Journal:  Semin Oncol       Date:  2000-08       Impact factor: 4.929

5.  Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.

Authors:  O Laccourreye; D Brasnu; V Bassot; M Ménard; D Khayat; H Laccourreye
Journal:  J Clin Oncol       Date:  1996-08       Impact factor: 44.544

Review 6.  Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.

Authors:  Robert Haddad; Roy B Tishler; Charles M Norris; Anand Mahadevan; Paul Busse; Lori Wirth; Laura A Goguen; Christopher A Sullivan; Rosemary Costello; Mary Ann Case; Marshall R Posner
Journal:  Oncologist       Date:  2003

Review 7.  End points for new agents in induction chemotherapy for locally advanced head and neck cancers.

Authors:  C Monnerat; S Faivre; S Temam; J Bourhis; E Raymond
Journal:  Ann Oncol       Date:  2002-07       Impact factor: 32.976

8.  Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.

Authors:  M Merlano; V Vitale; R Rosso; M Benasso; R Corvò; M Cavallari; G Sanguineti; A Bacigalupo; F Badellino; G Margarino
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

9.  Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.

Authors:  D M Brizel; M E Albers; S R Fisher; R L Scher; W J Richtsmeier; V Hars; S L George; A T Huang; L R Prosnitz
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

10.  Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC).

Authors:  C Domenge; C Hill; J L Lefebvre; D De Raucourt; B Rhein; P Wibault; P Marandas; B Coche-Dequeant; M Stromboni-Luboinski; H Sancho-Garnier; B Luboinski
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.